Acanthosis nigricans in a patient with metastatic insulinoma post peptide receptor radionuclide therapy

Acanthosis nigricans in a patient with metastatic insulinoma post peptide receptor radionuclide therapy

Blog Article

Acanthosis nigricans (AN) is a common dermatosis associated with hyperinsulinemia and insulin resistance.However, AN has been rarely reported in patients with insulinoma, Chef a state of persistent hyperinsulinemia.We present a case of metastatic insulinoma, in whom AN manifested after the first cycle of peptide receptor radionuclide therapy (PRRT).

A 40-year-old man was diagnosed with metastatic insulinoma after 5 months of symptomatic hypoglycemia.Within 1 month post PRRT, the patient became euglycemic but developed a pigmented, pruritic rash which was confirmed on COLOUR BATH RED biopsy as AN.We discuss the rare manifestation of AN in subjects with insulinoma, the role of insulin in the pathogenesis of AN, malignant AN in non-insulin-secreting malignancies and association with other insulin-resistant endocrinopathies such as acromegaly.